I joined the Schmidt group at the NKI in September 2026 as a PhD candidate. My doctoral research focuses on identifying novel time-varying factors (genetic, immunological, and treatment-related) that impact contralateral breast cancer risk, with the goal of improving risk prediction and clinical management for breast cancer survivors.
